Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Medical Device Maker Smith & Nephew Ramping Up Production In China Despite Counterfeiting Concerns

This article was originally published in PharmAsia News

Executive Summary

HONG KONG - Counterfeiting concerns and countermeasures remain a top priority for many major healthcare outfits that are establishing or expanding operations in China

You may also be interested in...

Lack Of Globally Accepted Definition of “Counterfeit Drug” Hurts U.S. FDA, Department Of Commerce Drive To Tackle Problem

Efforts by global stakeholders - including national governments, nongovernmental organizations, and drug companies - to curtail counterfeit drug production are hampered by the lack of an agreed-upon definition for "counterfeit.

Counterfeit Drugs Produced In China Still Threaten Chinese, U.S., Global Consumers

BEIJING - Unless China does more to crack down on counterfeiting and contamination in its pharmaceutical industry, the United States could see a repeat of Chinese-made drugs or raw components causing severe adverse reactions in American hospitals, according to a Washington, D.C.-based scholar

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts